AGM 2026: All 5 resolutions passed, capital reduction approved
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novyra Pharmachem Limited (formerly Bansisons Tea Industries) held its 39th AGM on June 25, 2026 via video conferencing. All 5 resolutions were passed: adoption of FY26 audited financials, re-appointment of Sandeep Agarwal, capital reduction scheme (98.53 percent in favor, 1.47 percent against), regularization of Anilkumar Amreliya as Executive Director, and his appointment as Managing Director. Voting turnout was low at 11.30 percent (about 5.49 lakh of 63.3 lakh shares); promoter group holding 14.65 lakh shares did not vote at all.
Capital reduction approved and new Managing Director appointed. Company has rebranded from tea to pharma. Low shareholder voting turnout is worth noting.